Peggy Scherle

Chief Tech/Sci/R&D Officer at PRELUDE THERAPEUTICS INCORPORATED

Net worth: 877 151 $ as of 2026-07-30

64 year

Health Technology

Consumer Services

Profile

Peggy Scherle is Chief Scientific Officer of Prelude Therapeutics, Inc. In her past career she held the position of Vice President-Preclinical Pharmacology at Incyte Corp. She received a doctorate from the University of Pennsylvania and an undergraduate degree from Michigan State University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
PRELUDE THERAPEUTICS, INC. 0.29%	2026-04-26	190,685 ( 0.29% )	877 151 $	2026-07-30

Peggy Scherle active positions

Companies	Position	Start
PRELUDE THERAPEUTICS INCORPORATED	Chief Tech/Sci/R&D Officer	2018-03-31

All active positions of Peggy Scherle

Former positions of Peggy Scherle

Companies	Position	End
INCYTE CORPORATION	Corporate Officer/Principal	2018-02-28

See the detail of Peggy Scherle's experience

Training of Peggy Scherle

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Peggy Scherle's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Incyte Corp. Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics	Health Technology
Michigan State University Michigan State University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Pennsylvania University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Prelude Therapeutics, Inc. Prelude Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines targeting chromatin function to treat cancer and rare diseases	Health Technology